Gastrodia elata bl attenuates methamphetamine-induced dopaminergic toxicity via inhibiting oxidative burdens. 2011

E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon 200-701, South Korea.

It has been recognized that Gastrodia elata Bl (GE), an oriental herb medicine, ameliorates various neurological disorders, that GE modulates the monoaminergic and GABAergic systems, and that GE possess antioxidant activities. We examined whether GE affects methamphetamine (MA)-induced striatal dopaminergic toxicity in mice. Treatment with MA (7.5 mg/kg, i.p. × 4) resulted in significant decreases in behavioural activity (as shown by locomotor activity and rota rod performance), dopamine level, tyrosine hydroxylase (TH) activity, and TH protein expression (as evaluated by immunocytochemistry and western blot analysis). In addition, MA treatment showed significant increases in lipid peroxidation [as evaluated by 4-hydroxy-2-nonenal (4-HNE) expression and malondialdehyde formation], protein oxidation (as shown by protein carbonyl expression and its formation), and reactive oxygen species (ROS) formation. Treatment with GE significantly attenuates MA-induced behavioural and dopaminergic impairments, and oxidative stresses in a dose-dependent manner. Our results suggest that GE treatment shows anti-dopaminergic effects in response to MA insult via, at least in part, inhibiting oxidative stresses in the striatum of the mice.

UI MeSH Term Description Entries

Related Publications

E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
June 1998, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
March 2011, Current neuropharmacology,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
January 1988, Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College = Chung-kuo i hsueh k'o hsueh yuan, Chung-kuo hsieh ho i k'o ta hsueh hsueh pao,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
November 2023, The International journal of neuroscience,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
February 2000, Brain research,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
January 2014, The American journal of Chinese medicine,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
December 2018, Neurochemical research,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
January 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
April 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
E-J Shin, and J-H Bach, and T-T L Nguyen, and X-K T Nguyen, and B-D Jung, and K-W Oh, and M J Kim, and S K Ko, and C G Jang, and S F Ali, and H-C Kim
September 1988, Zhong yao tong bao (Beijing, China : 1981),
Copied contents to your clipboard!